Home    Back

Procedure: posterolateral spinal fusion with instrumentation    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
70Spinal stenosis1

70. Spinal stenosis    [ 91 clinical trials,   195 drugs,   (DrugBank: 54 drugs),   60 drug target genes,   85 drug target pathways]
Searched query = "Spinal stenosis", "Extensive spinal canal stenosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 91 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT00549913
(ClinicalTrials.gov)		October 200724/10/2007Study of 3 Doses of NeoFuse Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion (PLF)A Dose-escalation Study to Assess the Feasibility and Safety of 3 Different Doses of NeoFuse When Combined With MasterGraft Granules in Subjects Requiring Posterolateral Lumbar Fusion With Instrumentation.Degenerative Disc Disease;Spondylolisthesis;Spinal StenosisBiological: NeoFuse;Procedure: posterolateral spinal fusion with instrumentationMesoblast, Ltd.NULLCompleted18 YearsN/AAll6Phase 1;Phase 2United States